Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Cancundude

Rank: Treasurer [?]

Points: 1672 [?]

Votes: 30 Score: 2.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial

in response to

Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial

Nextblockbuster

posted on Dec 22, 2020 08:59AM

Wow what a bunch of Debbie Downers! I get everyone is tired of this investment but for crying out loud look back at all the posts of the last 6 months and almost all are posts are grumblings about no news. Well we got some great news. I admit my first thought was what a great diversion for DM on the morning of the AGM. Having said that put your emotions aside and this announcement just adds to the potential of this drug. People RVX has an amazing proven safety profile that alone is a huge bonus. Clearly the ghost of that Sanfran guy has infected this board and has spread with the same efficiency as C-19. Anyways all you pouters have an amazing day and please sell as I will gladly scoop up your shares.